TNFSF13B and systemic lupus erythematosus: conducted a prospective evaluation of 245 SLE patients, revealing that circulating BLYS levels correlated with anti-double-stranded DNA antibody titers and SELENA-SLEDAI scores (another measure of SLE activity), further supporting the association between BLYS levels and SLE disease activity [65].